MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 24 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,723,000 | +49.2% | 2,253,118 | +19.3% | 0.29% | -86.5% |
| Q1 2020 | $3,835,000 | -34.2% | 1,889,100 | -30.0% | 2.17% | +138.0% |
| Q4 2019 | $5,832,000 | -8.5% | 2,700,000 | -34.8% | 0.91% | -8.8% |
| Q3 2019 | $6,377,000 | -61.0% | 4,140,819 | +5.1% | 1.00% | -9.4% |
| Q2 2019 | $16,354,000 | +1.7% | 3,940,819 | +2.5% | 1.10% | -29.2% |
| Q1 2019 | $16,074,000 | +31.5% | 3,845,407 | -9.7% | 1.56% | -37.1% |
| Q4 2018 | $12,224,000 | -44.1% | 4,259,367 | +94.7% | 2.47% | +70.4% |
| Q3 2018 | $21,874,000 | +11.3% | 2,187,367 | -21.3% | 1.45% | -17.6% |
| Q2 2018 | $19,650,000 | +61.3% | 2,779,321 | -12.8% | 1.76% | +49.4% |
| Q1 2018 | $12,179,000 | -34.5% | 3,188,221 | +39.9% | 1.18% | -35.3% |
| Q4 2017 | $18,595,000 | +18.0% | 2,278,848 | -15.1% | 1.82% | -45.2% |
| Q3 2017 | $15,760,000 | +1401.0% | 2,684,848 | +250.3% | 3.32% | +1181.9% |
| Q2 2017 | $1,050,000 | -23.5% | 766,448 | -1.1% | 0.26% | -36.8% |
| Q1 2017 | $1,372,000 | – | 775,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|